{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:34:04Z","timestamp":1780475644326,"version":"3.54.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Science and Technology Department of Shaanxi Province, China","award":["2022SF-564"],"award-info":[{"award-number":["2022SF-564"]}]},{"name":"Innovation Team of Shaanxi Provincial Health and Reproductive Medicine Research","award":["2023TD-04"],"award-info":[{"award-number":["2023TD-04"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Does the intravenous administration of Atosiban around the time of frozen blastocyst transfer to reduce uterine contractility increase the likelihood of live birth in individuals undergoing ART treatment?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>In individuals with a history of one previous implantation failure, Atosiban did not significantly increase the live birth rates following frozen blastocyst transfer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Excessive uterine contraction waves during the embryo transfer procedure have been associated with decreased pregnancy rates. Atosiban, an oxytocin receptor antagonist, could reduce uterine contractions and potentially enhance implantation success in ART. However, data are inconclusive.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>This study is a randomized, controlled, single-center, randomized, placebo-controlled clinical trial. Recruitment was from July 2019 to June 2023, with follow-up until May 2024. Participants, treating clinicians and embryologists were blinded to group assignment. Participants were randomized in a 1:1 ratio to receive intravenous Atosiban (37.5\u2009mg) (n\u2009=\u2009549) or placebo 30\u2009min (n\u2009=\u2009551) before the transfer procedure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Eleven hundred individuals scheduled for single frozen blastocyst transfer who had previously experienced one episode of implantation failure during ART. Uterine contractility was assessed via transvaginal ultrasound before administering the assigned intervention. The primary outcome was live birth. A pre-specified subgroup analysis was performed in individuals with and without abnormal uterine contractions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>Of the 1100 randomized participants (mean age, 31\u2009years), 1099 (99.9%) were assessed for the primary outcomes, with the exception of one participant in the placebo group who was lost to follow-up after clinical pregnancy. Live birth occurred in 272\/549 (49.5%) in the Atosiban group and 246\/550 (44.7%) in the placebo group (absolute difference 4.8%, 95% CI \u22121.1 to 10.7; risk ratio [RR] 1.11, 95% CI 0.98 to 1.26; P\u2009=\u20090.10). Uterine contractility was evaluated in 720 participants (65% of the total cohort). Among them, 163 participants (23%) with abnormal contractions had live birth rates of 51.9% and 39.3% in the Atosiban and placebo groups, respectively (absolute difference 12.6%, 95% CI \u22122.6 to 27.8; RR 1.32, 95% CI 0.94 to 1.86; P\u2009=\u20090.11).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The study\u2019s findings may not be widely applicable due to its single-center design, subjective video assessments, and focus on a specific subset of individuals experiencing failed embryo implantation, potentially introducing biases and confounding factors. Additionally, the limited examination of uterine contractions in only 65% of participants and the absence of re-evaluation due to resource constraints restrict the study\u2019s analytical power and the confirmation of Atosiban\u2019s effectiveness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Our study shows do not support the routine use of intravenous Atosiban to improve pregnancy outcomes among individuals undergoing frozen embryo transfers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>Science and Technology Department of Shaanxi Province, China (2022SF-564); Innovation Team of Shaanxi Provincial Health and Reproductive Medicine Research (2023TD-04); Key Industrial Chain Projects in Shaanxi Province: Research on Assisted Reproductive Technologies and Precision Prevention System for Genetic Diseases Preconception (2023-ZDLSF-48); Northwest Women\u2019s and Children\u2019s Hospital, Xi\u2019an, China and Ferring Pharmaceuticals (Shanghai) Company Limited. Ferring Pharmaceuticals (Shanghai) Company Limited supplied Atosiban free of charge. All funding parties had no role in study design, data collection, data analysis, data interpretation, writing of the report, or decisions to submit the results for publication. B.W.M. reports consultancy, travel support, and research funding from Merck and consultancy for Organon and Norgine; owning stock in ObsEva; and holding an NHMRC Investigator Grant (GNT1176437). W.L. is supported by an NHMRC Investigator grant (GNT2016729). All other authors declare no competing interests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>The RCT was registered in the Chinese Clinical Trial Registry; Study Number: ChiCTR1900022333.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION DATE<\/jats:title>\n                  <jats:p>5 April 2019.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DATE OF FIRST PATIENT\u2019S ENROLMENT<\/jats:title>\n                  <jats:p>1 July 2019.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deaf035","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T22:22:46Z","timestamp":1741126966000},"page":"808-817","source":"Crossref","is-referenced-by-count":3,"title":["Atosiban in individuals with previous implantation failure undergoing frozen blastocyst transfer: a randomized controlled trial"],"prefix":"10.1093","volume":"40","author":[{"given":"He","family":"Cai","sequence":"first","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Guangzhou Kapok Medical Group , Guang Zhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-0909","authenticated-orcid":false,"given":"Wentao","family":"Li","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology and Statistics Unit, Centre for Big Data Research in Health and School of Women\u2019s and Children\u2019s Health, The University of New South Wales , Sydney,","place":["Australia"]},{"name":"Department of Obstetrics and Gynaecology, School of Clinical Sciences at Monash Health, Monash University , Melbourne, VIC,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Bai","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xue","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhao","family":"Li","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhao","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Ma","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tian","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Xie","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jia","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Xi\u2019an Angel Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danmeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Translational Medicine Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben W","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, School of Clinical Sciences at Monash Health, Monash University , Melbourne, VIC,","place":["Australia"]},{"name":"Department of Obstetrics and Gynaecology, Amsterdam University Medical Centre , Amsterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7643-4124","authenticated-orcid":false,"given":"Juanzi","family":"Shi","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi\u2019an,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"2025060604120888900_deaf035-B1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.rbmo.2012.05.006","article-title":"The Alpha consensus meeting on cryopreservation key performance indicators and benchmarks: proceedings of an expert meeting","volume":"25","author":"Alpha Scientists In Reproductive Medicine","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"2025060604120888900_deaf035-B2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0002-9378(00)70351-6","article-title":"The role of diacylglycerol as a modulator of oxytocin-stimulated phasic contractions in myometrium from pregnant and nonpregnant rats","volume":"182","author":"Ascher-Landsberg","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"2025060604120888900_deaf035-B3","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.fertnstert.2019.07.584","article-title":"A randomized, double-blind, placebo-controlled, multi-center, phase 2 trial to investigate the effect of barusiban on implantation in IVF\/ICSI patients","volume":"112","author":"Bosch","year":"2019","journal-title":"Fertil Steril"},{"key":"2025060604120888900_deaf035-B4","doi-asserted-by":"crossref","first-page":"e076390","DOI":"10.1136\/bmjopen-2023-076390","article-title":"Effectiveness of atosiban in women with previous single implantation failure undergoing frozen-thawed blastocyst transfer: study protocol for a randomised controlled trial","volume":"13","author":"Cai","year":"2023","journal-title":"BMJ Open"},{"key":"2025060604120888900_deaf035-B5","first-page":"CD012375","article-title":"Oxytocin antagonists for assisted reproduction","volume":"9","author":"Craciunas","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025060604120888900_deaf035-B6","doi-asserted-by":"crossref","first-page":"e077111","DOI":"10.1136\/bmj-2023-077111","article-title":"Achieving more equitable access to assisted reproduction","volume":"385","author":"Dyer","year":"2024","journal-title":"BMJ"},{"issue":"Suppl 2","key":"2025060604120888900_deaf035-B7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1472-6483(10)60450-6","article-title":"Uterine dynamics: impact on the human reproduction process","volume":"18","author":"Fanchin","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2025060604120888900_deaf035-B8","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/humrep\/13.7.1968","article-title":"Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization","volume":"13","author":"Fanchin","year":"1998","journal-title":"Hum Reprod"},{"key":"2025060604120888900_deaf035-B9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0002-9378(95)90365-8","article-title":"The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions","volume":"173","author":"Goodwin","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"2025060604120888900_deaf035-B10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/humrep\/deaa369","article-title":"Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials","volume":"36","author":"Griesinger","year":"2021","journal-title":"Hum Reprod"},{"key":"2025060604120888900_deaf035-B11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.fertnstert.2018.03.033","article-title":"Improved outcomes after blastocyst-stage frozen-thawed embryo transfers compared with cleavage stage: a Society for Assisted Reproductive Technologies Clinical Outcomes Reporting System study","volume":"110","author":"Holden","year":"2018","journal-title":"Fertil Steril"},{"key":"2025060604120888900_deaf035-B13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0040-1716409","article-title":"Impairment of uterine contractility is associated with unexplained infertility","volume":"38","author":"Hunt","year":"2020","journal-title":"Semin Reprod Med"},{"key":"2025060604120888900_deaf035-B14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0015-0282(16)58207-7","article-title":"Endometrial wavelike movements during the menstrual cycle","volume":"65","author":"Ijland","year":"1996","journal-title":"Fertil Steril"},{"key":"2025060604120888900_deaf035-B15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0015-0282(98)00501-9","article-title":"Endometrial wave direction switch and the outcome of in vitro fertilization","volume":"71","author":"Ijland","year":"1999","journal-title":"Fertil Steril"},{"key":"2025060604120888900_deaf035-B16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7827-11-35","article-title":"A retrospective cross-sectional study: fresh cycle endometrial thickness is a sensitive predictor of inadequate endometrial thickness in frozen embryo transfer cycles","volume":"11","author":"Jimenez","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"2025060604120888900_deaf035-B17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S1701-2163(16)34278-5","article-title":"Uterine peristalsis in women with repeated IVF failures: possible therapeutic effect of hyoscine bromide","volume":"31","author":"Kido","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"2025060604120888900_deaf035-B18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.rbmo.2017.03.019","article-title":"Uterine peristalsis and fertility: current knowledge and future perspectives: a review and meta-analysis","volume":"35","author":"Kuijsters","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2025060604120888900_deaf035-B19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.rbmo.2012.05.014","article-title":"Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure","volume":"25","author":"Lan","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"2025060604120888900_deaf035-B20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.rbmo.2021.08.020","article-title":"Is oxytocin receptor antagonist administration around embryo transfer associated with IVF treatment success? A systematic review and meta-analysis","volume":"43","author":"Neumann","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"(12)","key":"2025060604120888900_deaf035-B34","first-page":"2687","article-title":"A randomized double blind comparison of atosiban in patients undergoing IVF treatment","volume":"29","author":"Ng EH, Li RH, Chen L, Lan VT, Tuong HM, Quan S","year":"2014","journal-title":"Hum Reprod"},{"key":"2025060604120888900_deaf035-B21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjc.1976.220","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design","volume":"34","author":"Peto","year":"1976","journal-title":"Br J Cancer"},{"key":"2025060604120888900_deaf035-B22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.fertnstert.2006.08.089","article-title":"Effect of atosiban on rabbit embryo development and human sperm motility","volume":"87","author":"Pierzynski","year":"2007","journal-title":"Fertil Steril"},{"key":"2025060604120888900_deaf035-B23","doi-asserted-by":"crossref","first-page":"213.e19","DOI":"10.1016\/j.fertnstert.2006.09.017","article-title":"Oxytocin antagonists may improve infertility treatment","volume":"88","author":"Pierzynski","year":"2007","journal-title":"Fertil Steril"},{"key":"2025060604120888900_deaf035-B24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.fertnstert.2016.02.022","article-title":"Importance of embryo transfer technique in maximizing assisted reproductive outcomes","volume":"105","author":"Schoolcraft","year":"2016","journal-title":"Fertil Steril"},{"key":"2025060604120888900_deaf035-B25","doi-asserted-by":"crossref","first-page":"654.e1","DOI":"10.1016\/j.ajog.2021.06.101","article-title":"Blastocyst morphology is associated with the incidence of monozygotic twinning in assisted reproductive technology","volume":"225","author":"Shi","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2025060604120888900_deaf035-B26","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/humrep\/dead197","article-title":"ART in Europe, 2019: results generated from European registries by ESHRE","volume":"38","author":"Smeenk","year":"2023","journal-title":"Hum Reprod"},{"key":"2025060604120888900_deaf035-B27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12958-022-00999-y","article-title":"A randomized double blind comparison of atosiban in patients with recurrent implantation failure undergoing IVF treatment","volume":"20","author":"Tang","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"2025060604120888900_deaf035-B28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.fertnstert.2023.02.014","article-title":"Recurrent implantation failure: reality or a statistical mirage?: Consensus statement from the July 1, 2022 Lugano Workshop on recurrent implantation failure","volume":"120","author":"The Writing Group for the Participants to the 2022 Lugano RIF Workshop","year":"2023","journal-title":"Fertil Steril"},{"key":"2025060604120888900_deaf035-B29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/humupd\/dmac009","article-title":"Interventions to optimize embryo transfer in women undergoing assisted conception: a comprehensive systematic review and meta-analyses","volume":"28","author":"Tyler","year":"2022","journal-title":"Hum Reprod Update"},{"key":"2025060604120888900_deaf035-B30","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0140-6736(16)00548-1","article-title":"Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial","volume":"387","author":"van Vliet","year":"2016","journal-title":"Lancet"},{"key":"2025060604120888900_deaf035-B31","doi-asserted-by":"crossref","first-page":"1161707","DOI":"10.3389\/fendo.2023.1161707","article-title":"Efficacy of atosiban for repeated embryo implantation failure: a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025060604120888900_deaf035-B32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-0528.2001.00043.x","article-title":"Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group","volume":"108","author":"Worldwide Atosiban versus Beta-Agonists Study Group","year":"2001","journal-title":"BJOG"},{"key":"2025060604120888900_deaf035-B33","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/humrep\/deu058","article-title":"Uterine peristalsis before embryo transfer affects the chance of clinical pregnancy in fresh and frozen-thawed embryo transfer cycles","volume":"29","author":"Zhu","year":"2014","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/5\/808\/62207130\/deaf035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/5\/808\/62207130\/deaf035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T08:12:18Z","timestamp":1749197538000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/40\/5\/808\/8046317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,2,28]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaf035","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,2,28]]}}}